Search - tctmd.com

Displaying 1 - 20 of 229

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

Presentation TCT 2025

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

Presenter: Terumitsu Hasebe

October 27, 2025

Presentation TCT 2025

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

Presenter: Minseob Jeong

October 26, 2025

News Daily News

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

L.A. McKeown

July 15, 2025

News Conference News CX Symposium 2025

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

L.A. McKeown

April 24, 2025

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept

Presenter: Terumitsu Hasebe

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

Presenter: Deepakraj Gajanana

October 27, 2024

Presentation TCT 2024

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

Presenter: Minseob Jeong

October 27, 2024

Presentation TCT 2024

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Presenter: Emi Kearon

October 27, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ISET 2024

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Caitlin E. Cox

January 31, 2024

News Conference News ISET 2024

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Caitlin E. Cox

January 25, 2024

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

TCT 910: Novel Hybrid Drug-Eluting BioStealth™ Stent for Below-the-Knee Lesions: Preclinical Results and Proposed Pivotal Clinical Trial

TCT 925: Peripheral Endovascular Intervention with Atherectomy in Below-The-Knee Arteries: A Report from The XLPAD Registry

POPCORN: Hemodialysis Patients Fare Well With Tailored PAD Therapies

Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Top Endovascular News of 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 709: The Novel Hybrid Nano-coating Ni-Ti stent for below-the-knee atherosclerotic disease: The Newest “Leave the Right Thing Behind”Concept

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 397: Comparative Outcomes of Below-the-Knee CTO vs Non-CTO Peripheral Artery Interventions From the XLPAD Registr

TCT 396: Outcomes of Below the Knee Chronic Total Occlusions Interventions: Insights From the XLPAD Registry

TCT 30: Comparative Outcomes of Non-Stent Below-the-Knee Peripheral Artery Interventions in Critical Limb Threatening Ischemia vs Intermittent Claudication From the XLPAD Registry

TCT 27: Pre-Clinical Data on a Novel Hybrid Drug-Eluting Stent With Nanocoating for Below-the-Knee Lesions: “Leave the Right Thing Behind”

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

FDA Approves Bioresorbable Scaffold for BTK Lesions

Will IVUS Ever Take Off in Peripheral Vascular Interventions?

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content